Nolato AB Series B | Balance Sheet

Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
321
256
410
421
677
958
Total Accounts Receivable
663
876
978
974
1,271
1,186
Inventories
259
264
279
393
530
566
Other Current Assets
19
27
24
33
163
34
Total Current Assets
1,262
1,423
1,691
1,821
2,641
2,744
Net Property, Plant & Equipment
733
894
952
1,205
1,243
1,518
Total Investments and Advances
2
2
2
2
2
2
Long-Term Note Receivable
2
1
1
1
1
1
Intangible Assets
538
549
543
849
813
780
Total Assets
2,573
2,914
3,274
3,978
4,803
5,156
ST Debt & Current Portion LT Debt
85
69
154
100
151
Accounts Payable
524
589
675
583
666
Income Tax Payable
7
41
10
10
56
Other Current Liabilities
384
430
407
489
859
Total Current Liabilities
1,000
1,129
1,246
1,182
1,732
Long-Term Debt
-
-
-
517
487
Provision for Risks & Charges
141
157
159
287
271
Deferred Taxes
48
16
25
42
51
Total Liabilities
1,225
1,347
1,515
2,128
2,644
Common Equity (Total)
1,348
1,567
1,759
1,850
2,159
Total Shareholders' Equity
1,348
1,567
1,759
1,850
2,159
Total Equity
1,348
1,567
1,759
1,850
2,159
Liabilities & Shareholders' Equity
2,573
2,914
3,274
3,978
4,803

About Nolato AB

View Profile
Address
Nolatovägen
Torekov SN 269 04
Sweden
Employees -
Website http://www.nolato.com
Updated 07/08/2019
Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. It operates through the following segments: Medical Solutions, Integrated Solutions, and Industrial Solutions. The Medical Solutions segment develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements.